Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia

Blood

Volumn 113, Issue 17, 2009, Pages 4086-4093

  Zhang, Wei ^a   Nardi, Michael A ^a   Borkowsky, William ^a   Li, Zongdong ^a   Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE ENVELOPE 1; GLYCOPROTEIN IIIA; GLYCOPROTEIN IIIA 49-66; IMMUNOGLOBULIN G; PEPTIDE; PEPTIDE LIBRARY; PHC09 PEPTIDE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; BETA3 INTEGRIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; CLONE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ABUSE; FEMALE; FRAGMENTATION REACTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 IMMUNE RELATED THROMBOCYTOPENIA; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MIXED INFECTION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PURIFICATION; SCREENING; SEQUENCE HOMOLOGY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WILD TYPE; ANIMAL; CELL COUNT; CROSS REACTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; OXIDATIVE STRESS;

ANIMALS; ANTIBODIES, VIRAL; BLOOD PLATELETS; CELL COUNT; CROSS REACTIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; INTEGRIN BETA3; MICE; MICE, KNOCKOUT; MOLECULAR MIMICRY; OXIDATIVE STRESS; PEPTIDE LIBRARY; THROMBOCYTOPENIA; VIRAL ENVELOPE PROTEINS;

EID: 65449118453     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-09-181073     Document Type: Article

References (27)

1. Karpatkin S, Nardi MA, Hymes KB. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci U S A. 1995;92:2263-2267.
2. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997;94:7589-7594.
3. Nardi M, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 2001;106:551-561. (Pubitemid 32879317)
4. Nardi M, Feinmark SJ, Hu L, Li Z, Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest. 2004;113:973-980. (Pubitemid 38544118)
5. Nardi MA, Gor Y, Feinmark SJ, Xu F, Karpatkin S. Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. Blood. 2007;110:1989-1996. (Pubitemid 47443913)
6. Li Z, Nardi MA, Wu J, et al. Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against {beta}3 integrin. J Biol Chem. 2008;283:3224-3230.
7. Mientjes GH, van Ameijden EJ, Mulder JW, et al. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men. Br J Haematol. 1992;82:615-619.
8. Jost J, Tauber MG, Luthy R, Siegenthaler W. [HIV-associated thrombocytopenia]. Schweiz Med Wochenschr. 1988;118:206-212.
9. Huemer HP, Prodinger WM, Larcher C, Most L, Dierich MP. Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts. Infection. 1990;18:122-123. (Pubitemid 20123458)
10. Quaranta JF, Delaney SR, Alleman S, et al. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol. 1994;42:29-32. (Pubitemid 24043049)
11. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis. 1996;23:1117-1125. (Pubitemid 26367502)
12. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996;174:690-695. (Pubitemid 26325882)
13. Sönnerborg A, Abebe A, Strannegard O. Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection. Infection. 1990;18:347-351.
14. Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood. 2005;106:572-576. (Pubitemid 40981253)
15. Nagamine T, Ohtuka T, Takehara K, et al. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996;24:135-140. (Pubitemid 26059114)
16. Samuel H, Nardi M, Karpatkin M, et al. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements. Br J Haematol. 1999;105:1086-1091. (Pubitemid 29309121)
17. Kajihara M, Kato S, Okazaki Y, et al. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1267-1276. (Pubitemid 36667305)
18. National Center for Biotechnology Information. Basic Local Alignment Search Tool (BLAST). http://www.ncbi.nlm.nih.gov/blast/Blast.cgi. Accessed September 2004.
19. Abruzzo GK, Gill CJ, Flattery AM, et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother. 2000;44:2310-2318.
20. Yong D, Wang H. Epitope mapping of polyclonal antibodies to HCV core protein using a phage peptide library. Chin J Microbiol Immunol. 1999;19:4-8.
21. Cieutat AM, Rosa JP, Letourneur F, Poncz M, Rifat S. A comparative analysis of cDNA-derived sequences for rat and mouse beta 3 integrins (GPIIIA) with their human counterpart. Biochem Biophys Res Commun. 1993;193:771-778. (Pubitemid 23214295)
22. Wellmann U, Werner A, Winkler TH. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur J Immunol. 2001;31:2800-2810. (Pubitemid 32898748)
23. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A. 1991;88:5547-5551. (Pubitemid 21914782)
24. Okamoto K, Moriishi K, Miyamura T, Matsuura Y. Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol. 2004;78:6370-6380. (Pubitemid 38715935)
25. Keck ZY, Sung VM, Perkins S, et al. Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J Virol. 2004;78:7257-7263. (Pubitemid 38781563)
26. Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A. 1985;82:8198-8202. (Pubitemid 16171061)
27. Yarchoan R, Redfield RR, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders: contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986;78:439-447. (Pubitemid 16074081)